{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T08:02:40Z","timestamp":1785052960759,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781071645659","type":"print"},{"value":"9781071645666","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4566-6_6","type":"book-chapter","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:22:40Z","timestamp":1754641360000},"page":"125-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using FFPEsig to Remove Formalin-Induced Artifacts and Characterize Mutational Signatures in Cancer"],"prefix":"10.1007","author":[{"given":"Qingli","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC et al (2013) Signatures of mutational processes in human cancer. Nature 500:415\u2013421","journal-title":"Nature"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12885-019-5677-2","volume":"19","author":"A Van Hoeck","year":"2019","unstructured":"Van Hoeck A, Tjoonk NH, van Boxtel R et al (2019) Portrait of a cancer: mutational signature analyses for cancer diagnostics. BMC Cancer 19:457","journal-title":"BMC Cancer"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41568-021-00377-7","volume":"21","author":"G Koh","year":"2021","unstructured":"Koh G, Degasperi A, Zou X et al (2021) Mutational signatures: emerging concepts, caveats and clinical applications. Nat Rev Cancer 21:619\u2013637","journal-title":"Nat Rev Cancer"},{"key":"6_CR4","first-page":"23","volume":"7","author":"SQ Wong","year":"2014","unstructured":"Wong SQ, Li J, Tan AYC et al (2014) Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genet 7:23","journal-title":"BMC Med Genet"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12864-019-6056-8","volume":"20","author":"AV Bhagwate","year":"2019","unstructured":"Bhagwate AV, Liu Y, Winham SJ et al (2019) Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples. BMC Genomics 20:689","journal-title":"BMC Genomics"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41467-022-32041-5","volume":"13","author":"Q Guo","year":"2022","unstructured":"Guo Q, Lakatos E, Bakir IA et al (2022) The mutational signatures of formalin fixation on the human genome. Nat Commun 13:4487","journal-title":"Nat Commun"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov LB, Jones PH, Wedge DC et al (2015) Clock-like mutational processes in human somatic cells. Nat Genet 47:1402\u20131407","journal-title":"Nat Genet"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1126\/science.aao3130","volume":"358","author":"J Drost","year":"2017","unstructured":"Drost J, van Boxtel R, Blokzijl F et al (2017) Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358:234\u2013238","journal-title":"Science"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ et al (2020) The repertoire of mutational signatures in human cancer. Nature 578:94\u2013101","journal-title":"Nature"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C et al (2013) From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 43:11.10.1\u201311.10.33","journal-title":"Curr Protoc Bioinformatics"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/ng.3036","volume":"46","author":"A Rimmer","year":"2014","unstructured":"Rimmer A, Phan H, Mathieson I et al (2014) Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet 46:912\u2013918","journal-title":"Nat Genet"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12864-019-6041-2","volume":"20","author":"EN Bergstrom","year":"2019","unstructured":"Bergstrom EN, Huang MN, Mahto U et al (2019) SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics 20:685","journal-title":"BMC Genomics"},{"key":"6_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196434","volume":"13","author":"LM Prentice","year":"2018","unstructured":"Prentice LM, Miller RR, Knaggs J et al (2018) Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice. PLoS One 13:e0196434","journal-title":"PLoS One"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm.3559","volume":"20","author":"EM Van Allen","year":"2014","unstructured":"Van Allen EM, Wagle N, Stojanov P et al (2014) Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 20:682\u2013688","journal-title":"Nat Med"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6890-4-1","volume":"4","author":"N Quach","year":"2004","unstructured":"Quach N, Goodman MF, Shibata D (2004) In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR. BMC Clin Pathol 4:1","journal-title":"BMC Clin Pathol"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"16895","DOI":"10.1074\/jbc.R400006200","volume":"279","author":"TA Kunkel","year":"2004","unstructured":"Kunkel TA (2004) DNA replication fidelity. J Biol Chem 279:16895\u201316898","journal-title":"J Biol Chem"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"287430","DOI":"10.1155\/2014\/287430","volume":"2014","author":"P McInerney","year":"2014","unstructured":"McInerney P, Adams P, Hadi MZ (2014) Error rate comparison during polymerase chain reaction by DNA polymerase. Mol Biol Int 2014:287430","journal-title":"Mol Biol Int"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1101\/gr.1.1.17","volume":"1","author":"KA Eckert","year":"1991","unstructured":"Eckert KA, Kunkel TA (1991) DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl 1:17\u201324","journal-title":"PCR Methods Appl"}],"container-title":["Methods in Molecular Biology","Cancer Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4566-6_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T07:57:10Z","timestamp":1785052630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4566-6_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071645659","9781071645666"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4566-6_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"9 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"TG is named as a coinventor on patent applications that describe a method for TCR sequencing (GB2305655.9, also with AMB), a method to measure evolutionary dynamics in cancers using DNA methylation (GB2317139.0), and a method to infer drug resistance mechanisms from barcoding data (GB2501439.0). TG has received honorarium from Genentech and consultancy fees from DAiNA therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}